Cannabis Legalization's Effects on Youth and Adult Nicotine and Tobacco Use

NIH RePORTER · NIH · R37 · $521,709 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY The past 20 years have seen significant changes in the US’s legal cannabis landscape alongside marked changes in tobacco use, the leading cause of preventable mortality. Yet recreational cannabis legalization’s (RCL’s) effects on tobacco product use remain unclear: few peer-reviewed studies directly test these effects and quasi-experimental analyses—methods to generate causal estimates in the absence of randomization— yield mixed findings on whether cannabis is an economic complement or substitute for cigarettes. These dynamics are crucial: laws increasing cannabis access will decrease use of its substitutes and increase use of its complements. Moreover, quasi-experimental studies largely ignore RCL’s effects on use of non-cigarette tobacco products like cigars and electronic nicotine delivery systems (ENDS), as well as potential effects of state cannabis policy details (e.g., tax rates, formulation restrictions) and local cannabis laws (e.g., local taxes, home delivery bans). If such effects are not anticipated, policymakers’ expectations of RCL’s costs and benefits will be incorrect, and both state and local policymakers may miss opportunities to structure cannabis laws in a manner that better protects their community’s health. To address this, we will compile a cannabis policy database covering state RCL policy details, local cannabis policies, and retailer density, and match it to nationally representative, restricted-use data from the National Survey on Drug Use and Health. Aim 1A will use these data to characterize variation in local access to cannabis retailers, local cannabis policies, and state RCL policy details likely to impact cannabis access and use within RCL states. Aim 1B will assess these policies’ relationships to cannabis retailer density, perceived ease of cannabis access, and cannabis use, elucidating their strength as unconfounded proxies for local cannabis retailer density and ease of access, and clarifying whether the policies’ effects on cannabis use are strong enough to allow instrumental variable analyses of cannabis use’s effect on tobacco product use. Considering cigarettes, cigars, ENDS, and blunts, Aim 2 will estimate RCL’s direct effects on adult tobacco product use, test for effect modification from state RCL policy details and local cannabis laws, and simulate implications for tobacco product use under alternative RCL scenarios (e.g., federal RCL, different cannabis tax rates, preempting local bans on retail sales). Aim 3 will conduct parallel analyses and simulations for 12-20 year-olds. Results will extend the literature on RCL’s effects on tobacco product use by accounting for a range of tobacco products, and increase its rigor by considering effect modification due to variation in state policy details and local cannabis laws, separately for underage versus 21+ age-groups. Moreover, simulations of alternative policies’ effects on tobacco and nicotine use will clarify potential unanticipated cos...

Key facts

NIH application ID
10929558
Project number
5R37DA058005-02
Recipient
YALE UNIVERSITY
Principal Investigator
Abigail S. Friedman
Activity code
R37
Funding institute
NIH
Fiscal year
2024
Award amount
$521,709
Award type
5
Project period
2023-09-15 → 2028-07-31